| Published Application/Species/Sample/Dilution | Reference |
|---|
- immunocytochemistry; human; 1:50; loading ...; fig 1d
| Seol B, Kim Y, Cho Y. Modeling Sialidosis with Neural Precursor Cells Derived from Patient-Derived Induced Pluripotent Stem Cells. Int J Mol Sci. 2021;22: pubmed publisher |
- immunocytochemistry; mouse; 1:100; fig 5g
| Di Luca M, Fitzpatrick E, Burtenshaw D, Liu W, Helt J, Hakimjavadi R, et al. The calcium binding protein S100β marks hedgehog-responsive resident vascular stem cells within vascular lesions. NPJ Regen Med. 2021;6:10 pubmed publisher |
| Hogrebe N, Schmidt M, Augsornworawat P, Gale S, Shunkarova M, Millman J. Depolymerizing F-actin accelerates the exit from pluripotency to enhance stem cell-derived islet differentiation. bioRxiv. 2025;: pubmed publisher |
| Hern xe1 ndez D, Morgan Schlicht S, Elli Clarke J, Daniszewski M, Karch C, Goate A, et al. Generation of a gene-corrected human isogenic iPSC line from an Alzheimer's disease iPSC line carrying the PSEN1 H163R mutation. Stem Cell Res. 2024;79:103495 pubmed publisher |
| Clua Provost C, Auboyer L, Rovelet Lecrux A, Monzo C, Schob E, Andreux F, et al. Generation of induced pluripotent stem cell lines IRMBi003-A and IRMBi003-B from a healthy donor to model Alzheimer's disease. Stem Cell Res. 2023;73:103250 pubmed publisher |
| She L, Li X, Bai M. Generation of an induced pluripotent stem cell line XJHi001-A from a fibronectin glomerulopathy patient carrying a heterozygous NM_212482.2(C.5888-1G > C) mutation in the FN1 gene. Stem Cell Res. 2023;72:103203 pubmed publisher |
| Provost C, Auboyer L, Rovelet Lecrux A, Monzo C, Schob E, Lehmann S, et al. Establishment of induced pluripotent stem cells IRMBi005-A from a patient with sporadic Alzheimer's disease. Stem Cell Res. 2023;72:103216 pubmed publisher |
| Yu L, Logsdon D, Pinzon Arteaga C, Duan J, Ezashi T, Wei Y, et al. Large-scale production of human blastoids amenable to modeling blastocyst development and maternal-fetal cross talk. Cell Stem Cell. 2023;30:1246-1261.e9 pubmed publisher |
| Jiang Z, Sun W, Zhang Q, Wang P. Generation of an induced pluripotent stem cell line (ZSZOCi001-A) from a patient with Knobloch syndrome caused by biallelic mutations in the gene COL18A1. Stem Cell Res. 2023;70:103131 pubmed publisher |
| Isono W, Kawasaki T, Ichida J, Nagasaka K, Hiraike O, Umezawa A, et al. Transcriptomic analysis of feeder-free culture system for maintaining naïve-state pluripotency in human pluripotent stem cells. Stem Cell Investig. 2023;10:10 pubmed publisher |
| Son N, Son Y, Jung C, Son M. Generation of a human fibroblast-derived induced pluripotent stem cell line KRIBBi009-A from a patient with breast cancer. Stem Cell Res. 2023;68:103060 pubmed publisher |
| Morita K, Nakamura A, Machida M, Kawasaki T, Nakanishi R, Ichida J, et al. Efficient reprogramming of human fibroblasts using RNA reprogramming with DAPT and iDOT1L under normoxia conditions. Regen Ther. 2022;21:389-397 pubmed publisher |
| Li Y, Li Y, Liu H, Cheng L, Ma H, Xu X, et al. Generation of a human induced pluripotent stem cell line (LZUSHi002-A) from a MADD patient with ETFDH mutation. Stem Cell Res. 2022;64:102914 pubmed publisher |
| Chen Y, Huang P, Wen M, Pan M, Lee D, Chen T. Generation of a homozygous knock-in human embryonic stem cell line expressing mEos4b-tagged CTR1. Stem Cell Res. 2022;63:102845 pubmed publisher |
| Liu Y, Ling T, Wang H, Yang Y, Song W, Wang T. Generation of an integration-free induced pluripotent stem cell line (LZUSHI001-A) from an epileptic patient with DGKG mutation. Stem Cell Res. 2022;61:102768 pubmed publisher |
| Wang H, Luo Y, Li J, Guan J, Yang S, Wang Q. Generation of a gene corrected human isogenic iPSC line (CPGHi001-A-1) from a hearing loss patient with the TMC1 p.M418K mutation using CRISPR/Cas9. Stem Cell Res. 2022;60:102736 pubmed publisher |
| Xu Y, Wang X, Qiu T, Wang J, Wang Y, Wu B, et al. Generation of an induced pluripotent stem cell line (FDCHI007-A) derived from a patient with developmental and epileptic encephalopathy Type 31 carrying heterozygous c.545C > A mutation in DNM1 gene. Stem Cell Res. 2022;60:102709 pubmed publisher |
| Lin L, Shi K, Zhou S, Cai M, Zhang C, Sun Y, et al. SOX17 and PAX8 constitute an actionable lineage-survival transcriptional complex in ovarian cancer. Oncogene. 2022;41:1767-1779 pubmed publisher |
| Luo S, Xiao S, Ai Y, Wang B, Wang Y. Changes in the hepatic differentiation potential of human mesenchymal stem cells aged in vitro. Ann Transl Med. 2021;9:1628 pubmed publisher |
| Shin Y, Mun S, Lee J, Chung K, Kim M, Kun Cheon C, et al. Generation of human induced pluripotent stem cell line, KRIBBi003-A, from urinary cells of a patient with glycogen storage disease type IXa. Stem Cell Res. 2021;57:102584 pubmed publisher |
| Fan T, He J, Wang Y, Yu J, Sun W. Generation of an induced pluripotent stem cell line (FDCHi006-A) from a 7-year-old girl with central precocious puberty. Stem Cell Res. 2021;56:102542 pubmed publisher |
| COLLINS D, Osborn M, Steer C. Differentiation of immortalized human multi-lineage progenitor to alveolar type 2-like cells: angiotensin-converting enzyme 2 expression and binding of severe acute respiratory syndrome coronavirus 2 spike and spike 1 proteins. Cytotherapy. 2021;23:1064-1073 pubmed publisher |
| Hogrebe N, Maxwell K, Augsornworawat P, Millman J. Generation of insulin-producing pancreatic β cells from multiple human stem cell lines. Nat Protoc. 2021;16:4109-4143 pubmed publisher |
| Fischer I, Küchler J, Schaar C, Fisch T, Cernoch J, Fischer K, et al. Generation of human induced pluripotent stem cell lines from 2 patients with MIRAGE syndrome. Stem Cell Res. 2021;54:102417 pubmed publisher |
| Gao X, Li G, Deng H, Feng W, Li Y, Liu M, et al. Generation of an iPSC line (GWCMCi002-A) from an X-linked Alport syndrome patient with a hemizygous splicing mutation (NM_000495.4, c. 1517-1 G > T) in the COL4A5 gene. Stem Cell Res. 2021;53:102388 pubmed publisher |
| Li J, Wu K, Guan J, Wang Q, Wang H. Generation of a human induced pluripotent stem cell line (CPGHi003-A) from an auditory neuropathy patient with AIFM1 p.R422Q mutation. Stem Cell Res. 2021;53:102376 pubmed publisher |
| Jia N, Gong X, Chen J, Yang T, Bao C, Shen J, et al. Generation of an induced pluripotent stem cell line (OGHFUi001-A) from a type 1 early infantile epileptic encephalopathy with ARX mutation. Stem Cell Res. 2021;53:102367 pubmed publisher |
| Li N, Lin S, Li Y, Sun J, Zhang L, Chen M. An induced pluripotent stem cell line (GZHMCi004-A) derived from a fetus with heterozygous G380R mutation in FGFR3 gene causing achondroplasia. Stem Cell Res. 2021;53:102322 pubmed publisher |
| Gao X, Qiu S, Wang W, Kang D, Su N, Dai P, et al. Generation of a gene corrected human isogenic iPSC line (CPGHi002-A-1) from a DDOD patient with heterozygous c.1516 C>T mutation in the ATP6V1B2 gene. Stem Cell Res. 2021;53:102271 pubmed publisher |
| Sun X, Zhou X, Dong B, Wang C, Xiao X, Wang Y. Generation of a gene-corrected isogenic iPSC line (AHQUi001-A-1) from a patient with familial hypertriglyceridemia (FHTG) carrying a heterozygous p.C310R (c.928 T > C) mutation in LPL gene using CRISPR/Cas9. Stem Cell Res. 2021;52:102230 pubmed publisher |
| Chen M, Lin S, Li N, Li Y, Li Y, Zhang L. An induced pluripotent stem cell line (GZHMCi003-A) derived from a fetus with exon 3 heterozygous deletion in RUNX2 gene causing cleidocranial dysplasia. Stem Cell Res. 2021;51:102166 pubmed publisher |
| Koike H, Iwasawa K, Ouchi R, Maezawa M, Kimura M, Kodaka A, et al. Engineering human hepato-biliary-pancreatic organoids from pluripotent stem cells. Nat Protoc. 2021;16:919-936 pubmed publisher |
| Isono W, Kawasaki T, Ichida J, Ayabe T, Hiraike O, Umezawa A, et al. The combination of dibenzazepine and a DOT1L inhibitor enables a stable maintenance of human naïve-state pluripotency in non-hypoxic conditions. Regen Ther. 2020;15:161-168 pubmed publisher |
| Gao X, Liao X, Zhang J, Lin J, Tan M. Derivation of an induced pluripotent stem cell line (GWCMCi001-A) from PBMCs of a four-year-old male patient with Immunoglobulin A nephropathy. Stem Cell Res. 2020;50:102123 pubmed publisher |
| Zhu Y, Zhang S, Wu X, Lian T, He Y, Zhang Z, et al. Generation of an induced pluripotent stem cell line (PUMCHi006-A) derived from a patient with pulmonary arterial hypertension carrying heterozygous c.1339 G > A mutation in PTGIS gene. Stem Cell Res. 2020;49:102088 pubmed publisher |
| Ohta E, Sone T, Ukai H, Hisamatsu T, Kitagawa T, Ishikawa M, et al. Generation of gene-corrected iPSCs line (KEIUi001-A) from a PARK8 patient iPSCs with familial Parkinson's disease carrying the I2020T mutation in LRRK2. Stem Cell Res. 2020;49:102073 pubmed publisher |
| Gao X, Qiu S, Feng M, Huang S, Kang D, Han M, et al. Establishment of human induced pluripotent stem cell line (CPGHi002-A) from a 10-month-old female patient with DDOD syndrome carrying a heterozygous c.1516 C > T mutation in ATP6V1B2. Stem Cell Res. 2020;48:101986 pubmed publisher |
| Zheng Z, Lu W, Pei Z, Chen J, Yang T, Luo F. Generation of an induced pluripotent stem cell line (CHFUi001-A) from an osteogenesis imperfecta patient with COL1A2 mutation. Stem Cell Res. 2020;47:101907 pubmed publisher |
| Aravalli R, COLLINS D, Hapke J, Crane A, Steer C. Hepatic Differentiation of Marmoset Embryonic Stem Cells and Functional Characterization of ESC-Derived Hepatocyte-Like Cells. Hepat Med. 2020;12:15-27 pubmed publisher |
| Zhou H, Zhou X, Lu J, Jia W, Kang J. An induced pluripotent stem cell line (SHEHi002-A (5426))from a patient of long QT syndrome type 8 with c.2573G>A mutation in the gene CACNA1C. Stem Cell Res. 2020;43:101731 pubmed publisher |
| Wang Q, Vossen A, Ikeda Y, Devaux P. Measles vector as a multigene delivery platform facilitating iPSC reprogramming. Gene Ther. 2019;26:151-164 pubmed publisher |
| Jeon H, Kim J, Choi J, Han E, Song C, Lee J, et al. Effects of the Extracts from Fruit and Stem of Camellia japonica on Induced Pluripotency and Wound Healing. J Clin Med. 2018;7: pubmed publisher |
| Tandon R, Brändl B, Baryshnikova N, Landshammer A, Steenpaß L, Keminer O, et al. Generation of two human isogenic iPSC lines from fetal dermal fibroblasts. Stem Cell Res. 2018;33:120-124 pubmed publisher |
| Yu L, Li J, Hong J, Takashima Y, Fujimoto N, Nakajima M, et al. Low Cell-Matrix Adhesion Reveals Two Subtypes of Human Pluripotent Stem Cells. Stem Cell Reports. 2018;11:142-156 pubmed publisher |
| Hayer S, Schelling Y, Hoeflinger P, Hauser S, Schols L. Generation of an induced pluripotent stem cell line from a patient with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP): HIHCNi003-A. Stem Cell Res. 2018;30:206-209 pubmed publisher |
| Wu X, Dao Thi V, Huang Y, Billerbeck E, Saha D, Hoffmann H, et al. Intrinsic Immunity Shapes Viral Resistance of Stem Cells. Cell. 2018;172:423-438.e25 pubmed publisher |
| Son M, Lee M, Jeon H, Seol B, Kim J, Chang J, et al. Generation and characterization of integration-free induced pluripotent stem cells from patients with autoimmune disease. Exp Mol Med. 2016;48:e232 pubmed publisher |
| Yu J, Ramasamy T, Murphy N, Holt M, Czapiewski R, Wei S, et al. PI3K/mTORC2 regulates TGF-β/Activin signalling by modulating Smad2/3 activity via linker phosphorylation. Nat Commun. 2015;6:7212 pubmed publisher |
| Lankford L, Selby T, Becker J, Ryzhuk V, Long C, Farmer D, et al. Early gestation chorionic villi-derived stromal cells for fetal tissue engineering. World J Stem Cells. 2015;7:195-207 pubmed publisher |
| Tian L, Prasad N, Jang Y. In Vitro Modeling of Alcohol-Induced Liver Injury Using Human-Induced Pluripotent Stem Cells. Methods Mol Biol. 2016;1353:271-83 pubmed publisher |
| Thatava T, Kudva Y, Edukulla R, Squillace K, De Lamo J, Khan Y, et al. Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells. Mol Ther. 2013;21:228-39 pubmed publisher |
| Sui L, Mfopou J, Geens M, Sermon K, Bouwens L. FGF signaling via MAPK is required early and improves Activin A-induced definitive endoderm formation from human embryonic stem cells. Biochem Biophys Res Commun. 2012;426:380-5 pubmed publisher |
| Sui L, Mfopou J, Chen B, Sermon K, Bouwens L. Transplantation of human embryonic stem cell-derived pancreatic endoderm reveals a site-specific survival, growth, and differentiation. Cell Transplant. 2013;22:821-30 pubmed |
| Ohmine S, Squillace K, Hartjes K, Deeds M, Armstrong A, Thatava T, et al. Reprogrammed keratinocytes from elderly type 2 diabetes patients suppress senescence genes to acquire induced pluripotency. Aging (Albany NY). 2012;4:60-73 pubmed |
| Ohmine S, Dietz A, Deeds M, Hartjes K, Miller D, Thatava T, et al. Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells. Stem Cell Res Ther. 2011;2:46 pubmed publisher |
| Thatava T, Nelson T, Edukulla R, Sakuma T, Ohmine S, Tonne J, et al. Indolactam V/GLP-1-mediated differentiation of human iPS cells into glucose-responsive insulin-secreting progeny. Gene Ther. 2011;18:283-93 pubmed publisher |
| Stefanovic S, Abboud N, Désilets S, Nury D, Cowan C, Puceat M. Interplay of Oct4 with Sox2 and Sox17: a molecular switch from stem cell pluripotency to specifying a cardiac fate. J Cell Biol. 2009;186:665-73 pubmed publisher |
| Tesar P, Chenoweth J, Brook F, Davies T, Evans E, Mack D, et al. New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature. 2007;448:196-9 pubmed |
| Vallier L, Alexander M, Pedersen R. Conditional gene expression in human embryonic stem cells. Stem Cells. 2007;25:1490-7 pubmed |
| Kim B, Kim S, Shim J, Woo D, Gil J, Kim S, et al. Neurogenic effect of vascular endothelial growth factor during germ layer formation of human embryonic stem cells. FEBS Lett. 2006;580:5869-74 pubmed |
